International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Late-Breaking Abstracts are accepted for significant new findings in TDM or CT research obtained after the deadline of regular abstract submission.
Submission period: From May 1st 0:00 JST until May 21st 23:59 JST sharp
The program committee will review novelty and significance of the submitted abstracts.
Only poster presentation is available for LB-abstract.
Authors presenting LB-abstract must register not later than June 30th, 2017.
Don’t miss the last chance to submit your abstract to the IATDMCT Congress.
The Scientific Program Committee invites the submission of abstracts on original work. Basically, abstracts can be submitted for consideration for a poster presentation. Some may be assigned as an oral presentation by the Committee. If you prefer a poster presentation only, please inform on the submission form. All successful abstracts will be published in the Congress App and will be published on the IATDMCT Congress website. Presenting authors must register before 31 May 2017.
Abstracts may be submitted on topics related to therapeutic drug monitoring and clinical toxicology. To be considered, each abstract must follow the required format outlined below. Additionally, each abstract must include sufficient data so that the reader can understand the study design, methods, results, and any conclusions that should be drawn from the study.
Non-members who wish to join IATDMCT or JSTDM can apply new membership. Please click the following URLs for details.
Please select one separately from Category A and B.
Abstract Submission is closed.